USE OF ANTI-HLA-DR ANTIBODY
PROBLEM TO BE SOLVED: To provide an anti-HLA-DR monoclonal antibody. SOLUTION: The invention provides an antibody or its functional fragment bonding to HLA-DR (antigen) having characteristics of (a) showing a life-prolonging effect on a nonhuman animal carrying cancer cells with HLA-DR expression an...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TAWARA TOMONORI KATAOKA YUKIRO |
| description | PROBLEM TO BE SOLVED: To provide an anti-HLA-DR monoclonal antibody. SOLUTION: The invention provides an antibody or its functional fragment bonding to HLA-DR (antigen) having characteristics of (a) showing a life-prolonging effect on a nonhuman animal carrying cancer cells with HLA-DR expression and (b) having a lower immune reaction inhibitory activity than L243; or an antibody or its functional fragment bonding to HLA-DR and showing an immunosuppressive activity comparable to or higher than mouse anti-HLA-DR monoclonal antibody L243 (ATCC HB55). COPYRIGHT: (C)2006,JPO&NCIPI |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2005325133A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2005325133A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2005325133A3</originalsourceid><addsrcrecordid>eNrjZJAODXZV8HdTcPQL8dT18HHUdQkCs538XSJ5GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8V4CRgYGpsZGpobGxozFRigBsbSCT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF ANTI-HLA-DR ANTIBODY</title><source>esp@cenet</source><creator>TAWARA TOMONORI ; KATAOKA YUKIRO</creator><creatorcontrib>TAWARA TOMONORI ; KATAOKA YUKIRO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide an anti-HLA-DR monoclonal antibody. SOLUTION: The invention provides an antibody or its functional fragment bonding to HLA-DR (antigen) having characteristics of (a) showing a life-prolonging effect on a nonhuman animal carrying cancer cells with HLA-DR expression and (b) having a lower immune reaction inhibitory activity than L243; or an antibody or its functional fragment bonding to HLA-DR and showing an immunosuppressive activity comparable to or higher than mouse anti-HLA-DR monoclonal antibody L243 (ATCC HB55). COPYRIGHT: (C)2006,JPO&NCIPI</description><edition>7</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051124&DB=EPODOC&CC=JP&NR=2005325133A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051124&DB=EPODOC&CC=JP&NR=2005325133A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAWARA TOMONORI</creatorcontrib><creatorcontrib>KATAOKA YUKIRO</creatorcontrib><title>USE OF ANTI-HLA-DR ANTIBODY</title><description>PROBLEM TO BE SOLVED: To provide an anti-HLA-DR monoclonal antibody. SOLUTION: The invention provides an antibody or its functional fragment bonding to HLA-DR (antigen) having characteristics of (a) showing a life-prolonging effect on a nonhuman animal carrying cancer cells with HLA-DR expression and (b) having a lower immune reaction inhibitory activity than L243; or an antibody or its functional fragment bonding to HLA-DR and showing an immunosuppressive activity comparable to or higher than mouse anti-HLA-DR monoclonal antibody L243 (ATCC HB55). COPYRIGHT: (C)2006,JPO&NCIPI</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAODXZV8HdTcPQL8dT18HHUdQkCs538XSJ5GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8V4CRgYGpsZGpobGxozFRigBsbSCT</recordid><startdate>20051124</startdate><enddate>20051124</enddate><creator>TAWARA TOMONORI</creator><creator>KATAOKA YUKIRO</creator><scope>EVB</scope></search><sort><creationdate>20051124</creationdate><title>USE OF ANTI-HLA-DR ANTIBODY</title><author>TAWARA TOMONORI ; KATAOKA YUKIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2005325133A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>TAWARA TOMONORI</creatorcontrib><creatorcontrib>KATAOKA YUKIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAWARA TOMONORI</au><au>KATAOKA YUKIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF ANTI-HLA-DR ANTIBODY</title><date>2005-11-24</date><risdate>2005</risdate><abstract>PROBLEM TO BE SOLVED: To provide an anti-HLA-DR monoclonal antibody. SOLUTION: The invention provides an antibody or its functional fragment bonding to HLA-DR (antigen) having characteristics of (a) showing a life-prolonging effect on a nonhuman animal carrying cancer cells with HLA-DR expression and (b) having a lower immune reaction inhibitory activity than L243; or an antibody or its functional fragment bonding to HLA-DR and showing an immunosuppressive activity comparable to or higher than mouse anti-HLA-DR monoclonal antibody L243 (ATCC HB55). COPYRIGHT: (C)2006,JPO&NCIPI</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2005325133A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE |
| title | USE OF ANTI-HLA-DR ANTIBODY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A39%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAWARA%20TOMONORI&rft.date=2005-11-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2005325133A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |